[1]耿 鹃,周 耀,刘旭辉.微小RNA-492、红细胞微粒水平与ST段抬高型急性心肌梗死患者冠状动脉病变严重程度关系研究[J].陕西医学杂志,2024,(9):1249-1253.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
　GENG Juan,ZHOU Yao,LIU Xuhui.Relationship between level of miR-492,erythrocyte microparticles and severity of coronary artery lesions in STEMI patients[J].,2024,(9):1249-1253.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
点击复制

微小RNA-492、红细胞微粒水平与ST段抬高型急性心肌梗死患者冠状动脉病变严重程度关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1249-1253
栏目:
临床检验
出版日期:
2024-09-05

文章信息/Info

Title:
Relationship between level of miR-492,erythrocyte microparticles and severity of coronary artery lesions in STEMI patients
作者:
耿 鹃; 周 耀; 刘旭辉
(淮安市第二人民医院心血管内科,江苏 淮安 223000)
Author(s):
GENG Juan; ZHOU Yao; LIU Xuhui
(Department of Cardiovascular Medicine,Huai'an Second People's Hospital,Huai'an 223000,China)
关键词:
ST段抬高型急性心肌梗死;  微小RNA-492;  红细胞微粒水平;  冠状动脉病变;  预测价值;  病变严重程度;  冠状动脉Gensini评分
Keywords:
ST-segment elevation acute myocardial infarction;  microRNA-492;  Erythrocyte microparticle level;  Coronary artery lesions;  Predictive value;  Lesion severity;  Gensini score of coronary artery
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.09.021
文献标志码:
A
摘要:
目的:探究微小RNA-492(miR-492)、红细胞微粒(RMPs)水平与ST段抬高型急性心肌梗死(STEMI)患者冠状动脉病变严重程度的关系。方法:选取STEMI患者83例为研究对象,入院后均进行Gensini积分评分,以评估患者冠脉病变严重程度。收集患者临床相关资料,检测miR-492和RMPs水平。分析患冠状动脉病变严重程度的影响因素,以及miR-492、RMPs对患者冠状动脉病变程度的预测效能。结果:83例患者Gensini总评分为(45.38±7.21)分,其中轻度35例、重度48例。重度病变组年龄≥60岁占比、miR-492、RMPs、心肌肌钙蛋白(cTnI)、脑钠肽(BNP)、超敏C-反应蛋白(hs-CRP)水平高于轻度病变组,LVEF水平低于轻度病变组(均P<0.05)。Logistic回归分析结果显示,miR-492、RMPs、hs-CRP水平是STEMI患者冠脉病变严重程度的独立危险因素,LVEF水平是独立保护因素(均P<0.05)。Pearson法分析显示,患者miR-492、RMPs水平与Gensini评分、hs-CRP呈正相关,与LVEF呈负相关(均P<0.05)。ROC曲线分析结果显示,miR-492、RMPs及两项联合预测STEMI患者冠脉病变严重程度的敏感度分别为72.20%、77.80%、87.00%,特异性分别为75.90%、79.30%、89.70%,曲线下面积(AUC)分别为0.828、0.813、0.944(均P<0.05)。结论:miR-492、RMPs水平是影响STEMI患者冠脉病变严重程度的独立危险因素,两者联合检测可有效预测患者病变严重程度。
Abstract:
Objective:To explore the relationship between the levels of microRNA-492(miR-492),erythrocyte microparticles(RMPs)and the severity of coronary artery lesions in patients with ST-segment elevation acute myocardial infarction(STEMI).Methods:A total of 83 patients with STEMI were retrospectively selected as the research objects.Gensini scores were performed for all patients after admission to evaluate the severity of coronary lesions.The clinical data of patients were collected,and the levels of miR-492 and RMPs were detected.The influencing factors of the severity of coronary artery disease were analyzed,and the predictive efficacy of miR-492 and RMPs on the severity of coronary artery disease in patients was analyzed.Results:The total Gensini score of 83 patients was 45.38±7.21,including 35 mild cases and 48 severe cases.The proportion of age ≥60 years old,the levels of miR-492,RMPs,cTnI,BNP and hs-CRP in the severe lesion group were higher than those in the mild lesion group,and the LVEF level was lower than that in the mild lesion group(all P<0.05).Logistic regression analysis showed that miR-492 level,RMPs level,hs-CRP level were independent risk factors for the severity of coronary artery lesions in patients with STEMI,and LVEF level was independent protective factor(all P<0.05).Pearson analysis showed that the levels of miR-492 and RMPs in patients were positively correlated with Gensini score and hs-CRP,and negatively correlated with LVEF(all P<0.05).ROC curve results showed that the sensitivity of miR-492,RMPs and their combination to predict the severity of coronary artery disease in patients with STEMI was 72.20%,77.80%,87.00% respectively,the specificity was 75.90%,79.30%,89.70% respectively,and the AUC were 0.828,0.813 and 0.944 respectively(all P<0.05).Conclusion:The levels of miR-492 and RMPs are independent risk factors for the severity of coronary artery lesions in patients with STEMI.The combined detection of miR-492 and RMPS can effectively predict the severity of coronary artery lesions in patients.

参考文献/References:

[1] KUNKEL K J,FULLER B,BASIR M B.Management of cardiogenic shock in patients with acute myocardial infarction[J].Interv Cardiol Clin,2021,10(3):345-357.
[2] 峁存,曾新春.急性心肌梗死经皮冠状动脉介入术治疗前后血清内皮细胞钙黏蛋白水平、血管生成素-2水平与预后相关性分析[J].陕西医学杂志,2022,51(10):1219-1222.
[3] 阮文婷,魏希进,管琳.血清NT-proBNP、Gal-3水平与急性ST段抬高型心肌梗死患者病情及近期预后的关系[J].中华保健医学杂志,2022,24(3):192-195.
[4] 刘超,刘楠,吴航,等.利拉鲁肽对急性ST段抬高型心肌梗死患者经皮冠状动脉介入术后无复流和心功能的影响[J].陕西医学杂志,2022,51(10):1294-1297,1312.
[5] 常琳,常佩云,刘娟.CK-MB、cTnI、冠脉造影及心电图联合诊断急性心肌梗死价值研究[J].分子诊断与治疗杂志,2020,12(8):1018-1021.
[6] SONG R,DASGUPTA C,MULDER C,et al.MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction[J].Circulation,2022,145(15):1140-1153.
[7] SHI L P,LIANG M,LI F F,et al.MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression[J].Eur Rev Med Pharmacol Sci,2019,23(3):992-1001.
[8] 姚振兴,陈职睿,郑凯文,等.急性心肌梗死患者外周血中微小RNA-492表达水平及临床意义[J].中华老年心脑血管病杂志,2022,24(2):159-162.
[9] BUERCK J P,FOSTER K M,LARSON P R,et al.Shear stimulated red blood cell microparticles:Effect on clot structure,flow and fibrinolysis[J].Biorheology,2023,59(1-2):43-59.
[10] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,《中国循环杂志》编辑委员会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
[11] GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
[12] TASHIRO H,TANAKA A,ISHII H,et al.Reduced exercise capacity and clinical outcomes following acute myocardial infarction[J].Heart Vessels,2020,35(8):1044-1050.
[13] WINDFELD-MATHIASEN J,CHANTAL D K M,SIGVARDSEN P E,et al.Development of myocardial fat in patients with acute myocardial infarction determined by cardiac computed tomography[J].JACC Cardiovasc Imaging,2022,15(6):1160-1162.
[14] 王朝歆,李岩,王超,等.芎归六君子汤治疗急性心肌梗死疗效及对患者再灌注损伤后心功能、氧化应激水平的影响[J].陕西中医,2021,42(11):1549-1552.
[15] LI J,WANG N,WEN X,et al.Serum miRNA-203 as a novel biomarker for the early prediction of acute ST-elevation myocardial infarction[J].J Cardiovasc Transl Res,2022,15(6):1406-1413.
[16] MA Z F,WANG N,ZHANG J,et al.Overexpression of miR-431 inhibits cardiomyocyte apoptosis following myocardial infarction via targeting HIPK3[J].Eur Rev Med Pharmacol Sci,2021,25(4):2056-2064.
[17] CHAN G C,THAN W H,KWAN B C,et al.Adipose expression of miR-130b and miR-17-5p with wasting,cardiovascular event and mortality in advanced chronic kidney disease patients[J].Nephrol Dial Transplant,2022,37(10):1935-1943.
[18] 王玮,王永,湛长青,等.单核细胞与高密度脂蛋白胆固醇比值联合平均血小板体积与急性心肌梗死冠状动脉病变严重程度分析[J].中国临床医生杂志,2023,51(6):664-666.
[19] 朱跃跃,卞茂红.红细胞微粒及其生物学性质的研究进展[J].临床输血与检验,2020,22(5):551-556.
[20] 郑国学,谭强,郑江华,等.红细胞微粒与动脉粥样硬化相关性研究进展[J].实用临床医药杂志,2021,25(6):113-117,132.
[21] SHIOZAKI M,INOUE K,SUWA S,et al.Clinical evaluation of a new high-sensitivity cardiac troponini assay for diagnosis and risk assessment of patients with suspected acute myocardial infarction[J].Cardiology,2021,146(2):172-178.
[22] LIU J,AO W,ZHOU J,et al.The correlation between PLR-NLR and prognosis in acute myocardial infarction[J].Am J Transl Res,2021,13(5):4892-4899.
[23] 于莉莉,孟中华,王婷婷,等.AIM2炎症小体在动脉粥样硬化中的研究进展[J].中国现代医学杂志,2023,33(8):50-55.
[24] RIDKER P M,BHATT D L,PRADHAN A D,et al.Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy:A collaborative analysis of three randomised trials[J].Lancet,2023,401(10384):1293-1301.
[25] SHAH A M,CLAGGETT B,PRASAD N,et al.Impact of sacubitril/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction:The PARADISE-MI echocardiographic substudy[J].Circulation,2022,146(14):1067-1081.

相似文献/References:

[1]龙继贤,高文妹.ST段抬高型急性心肌梗死早期脑钠肽水平变化及各个时间点检测对心力衰竭的诊断价值[J].陕西医学杂志,2019,(5):595.
　LONG Jixian,GAO Wenmei..The change of brain natriuretic peptide(BNP)concentration in the early stage of STsegment elevationacute myocardial infarction and the diagnostic value of BNP at different time points for heart failure at that time[J].,2019,(9):595.

备注/Memo

备注/Memo:
基金项目:江苏省自然科学基金资助项目(BK20211043)
更新日期/Last Update: 2024-09-04